Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
Israel
· Delayed Price · Currency is ILS · Price in ILA 1,180.00
+6.00 (0.51%)
Apr 28, 2026, 5:24 PM IDT
TLV:REKA Ratios and Metrics
Market cap in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 134 | 125 | 151 | 169 | 176 | 266 | Upgrade
|
| Market Cap Growth | -11.20% | -17.43% | -10.35% | -3.96% | -33.89% | -13.13% | Upgrade
|
| Enterprise Value | 262 | 254 | 295 | 338 | 321 | 420 | Upgrade
|
| Last Close Price | 11.74 | 10.94 | 13.25 | 14.78 | 15.39 | 22.40 | Upgrade
|
| PE Ratio | - | - | 24.37 | - | - | 40.12 | Upgrade
|
| PS Ratio | 0.45 | 0.42 | 0.47 | 0.52 | 0.60 | 1.01 | Upgrade
|
| PB Ratio | 0.93 | 0.87 | 0.93 | 1.08 | 1.08 | 1.54 | Upgrade
|
| P/TBV Ratio | 1.52 | 1.42 | 1.50 | 1.90 | 1.39 | 1.90 | Upgrade
|
| P/FCF Ratio | 22.62 | 21.08 | 8.47 | 10.01 | 5.48 | 34.59 | Upgrade
|
| P/OCF Ratio | 10.35 | 9.64 | 5.70 | 5.95 | 4.50 | 12.55 | Upgrade
|
| EV/Sales Ratio | 0.87 | 0.85 | 0.92 | 1.05 | 1.10 | 1.59 | Upgrade
|
| EV/EBITDA Ratio | 11.27 | 16.58 | 11.72 | 10.31 | 7.87 | 11.73 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 116.43 | 24.20 | 32.49 | Upgrade
|
| EV/FCF Ratio | 44.25 | 42.96 | 16.53 | 20.07 | 10.00 | 54.61 | Upgrade
|
| Debt / Equity Ratio | 0.92 | 0.92 | 0.83 | 1.18 | 1.02 | 0.96 | Upgrade
|
| Debt / EBITDA Ratio | 5.67 | 5.67 | 5.33 | 5.60 | 4.07 | 4.64 | Upgrade
|
| Debt / FCF Ratio | 22.35 | 22.35 | 7.52 | 10.89 | 5.17 | 21.59 | Upgrade
|
| Net Debt / Equity Ratio | 0.89 | 0.89 | 0.79 | 1.06 | 0.90 | 0.85 | Upgrade
|
| Net Debt / EBITDA Ratio | 8.34 | 8.34 | 5.05 | 5.01 | 3.57 | 4.12 | Upgrade
|
| Net Debt / FCF Ratio | 21.61 | 21.61 | 7.12 | 9.74 | 4.53 | 19.16 | Upgrade
|
| Asset Turnover | 0.69 | 0.69 | 0.69 | 0.69 | 0.66 | 0.62 | Upgrade
|
| Inventory Turnover | 2.67 | 2.67 | 2.79 | 2.56 | 2.35 | 2.12 | Upgrade
|
| Quick Ratio | 0.92 | 0.92 | 0.90 | 1.01 | 1.06 | 1.30 | Upgrade
|
| Current Ratio | 1.53 | 1.53 | 1.45 | 1.75 | 1.75 | 2.25 | Upgrade
|
| Return on Equity (ROE) | -11.81% | -11.81% | 3.91% | -4.35% | -1.22% | 3.91% | Upgrade
|
| Return on Assets (ROA) | -1.04% | -1.04% | -0.98% | 0.39% | 1.87% | 1.88% | Upgrade
|
| Return on Invested Capital (ROIC) | -2.62% | -2.58% | -1.89% | 0.93% | -24.16% | 3.60% | Upgrade
|
| Return on Capital Employed (ROCE) | -2.70% | -2.70% | -2.50% | 0.90% | 4.30% | 3.80% | Upgrade
|
| Earnings Yield | -13.49% | -14.47% | 4.10% | -4.10% | -1.16% | 2.49% | Upgrade
|
| FCF Yield | 4.42% | 4.74% | 11.80% | 9.99% | 18.25% | 2.89% | Upgrade
|
| Dividend Yield | - | - | - | - | - | 3.87% | Upgrade
|
| Total Shareholder Return | - | - | - | - | - | 3.87% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.